Author

T. Iwai

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Recurrence of cardiovascular events despite achieving LDL-C <1.4 mmol/L i in patients with coronary artery disease

The current ESC/EAS guideline recommends lowering LDL-C <1.4 mmol/L for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in very high-risk patients. However, despite favourable LDL-C control, atherosclerosis still continues to progress, which eventually causes cardiovascular events. Ther...

Y. Kataoka, S. Nicholls, S. Kitahara et al. · European Heart Journal · 0 citations

Open access Oct 2026

Circulating angiopoietin-like protein 3 levels and subsequent cardiovascular outcomes in patients with coronary artery disease

An increased risk of cardiovascular events was observed in patients with CAD who exhibited ANGPTL3> 363.4 ng/mL, and the findings suggest circulating ANGPTL3 as a potential therapeutic target to further mitigate subsequent cardiovascular events’ risks in patients with CAD.

S. Fujita, Y. Kataoka, N. Kuyama et al. · European Heart Journal · 0 citations

Open access Aug 2026

Lipidic Plaque Features of Polyvascular Disease in Response to Low-Density Lipoprotein Cholesterol <55 mg/dL: Implication of Circulating Lipoprotein(a) Levels.

Coronary atheroma in patients with PolyVD was resistant to lowering LDL-C <55 mg/dL, and lipoprotein(a) may be a potential therapeutic target to delipidate coronary atheroma.

A. Katasako-Yabumoto, Yu Kataoka, S. Nicholls et al. · Journal of the American Hear... · 0 citations